LifeSciVC

AUGUST 21, 2024

Drug development is a long process, and patients are waiting. Keeping ahead of schedule will help to maintain manufacturing efficiencies, ensure adequate supply and product quality, and meet development timelines. Don’t get me wrong. I know we all haven’t exactly been coasting this summer.

Clinical Trials 63

Clinical Trials Trials Disease Clinical Supply 63

Drug Target Review

SEPTEMBER 10, 2024

The current landscape of protein drug development is characterised by accelerated timelines where new drugs are approved in months rather than years. In recent years, the biopharmaceutical industry has identified rapid Toxicology (Tox) material supply as the new critical path to IND readiness.

Clinical Supply 64

Clinical Supply Drug Development Production Animal Testing 64

Drug Discovery World

MARCH 13, 2023

Repercussions of the Covid-19 pandemic The idea that the Covid-19 pandemic dramatically affected the CGT supply chain and upturned CGT manufacturing has dominated the conversation in the biotech sector 3. But now, the increased efficiency is likely making drug development cheaper.

Therapies 130

Therapies Drug Development Clinical Trials Cell Based Assays 130